Literature DB >> 11216967

Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes.

P Aukrust1, R K Berge, T Ueland, E Aaser, J K Damås, L Wikeby, A Brunsvig, F Müller, K Forfang, S S Frøland, L Gullestad.   

Abstract

OBJECTIVES: We sought to study the relationships between chemokines and oxidative stress in acute coronary syndrome.
BACKGROUND: In view of existing knowledge on the participation of leukocytes and oxidative stress in the pathogenesis of acute coronary syndrome, we hypothesized that chemokines may play a role in recruiting and activating leukocytes in this disorder.
METHODS: The levels of chemokines and oxidative stress were studied in 38 patients with stable and 38 with unstable angina and in 20 controls. In separate in vitro experiments the effect of chemokines on reactive oxygen species in monocytes and the effect of antioxidants on chemokine levels in these cells were also studied.
RESULTS: 1) Angina patients had raised serum levels of chemokines in both cross-sectional and longitudinal testing, with particularly high levels of interleukin (IL)-8, monocyte chemoattractant protein (MCP)-1 and macrophage inflammatory peptide (MIP)-1-alpha in unstable disease. 2) T cells, and particularly monocytes, seem to contribute to the raised IL-8, MCP-1 and MIP-1-alpha levels in unstable angina. 3) Concomitantly, and significantly correlated with MCP-1 and IL-8 levels, stable and particularly unstable angina patients had decreased plasma levels of antioxidants and increased lipid peroxidation, suggesting enhanced oxidative stress. 4) Monocyte chemoattractant protein-1 enhanced the generation of O2- in monocytes from unstable angina patients, and the antioxidant glutathione-monoethyl ester suppressed the production of IL-8 and MCP-1 in these cells.
CONCLUSIONS: Our findings suggest an interaction between chemokines and oxidative stress in unstable angina. This interaction may represent a vicious circle involved in the pathogenesis of acute coronary syndromes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11216967     DOI: 10.1016/s0735-1097(00)01110-4

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  29 in total

Review 1.  Chemokines in myocardial failure -- pathogenic importance and potential therapeutic targets.

Authors:  P Aukrust; J K Damås; L Gullestad; S S Frøland
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

2.  Enhanced external counterpulsation improves peripheral artery flow-mediated dilation in patients with chronic angina: a randomized sham-controlled study.

Authors:  Randy W Braith; C Richard Conti; Wilmer W Nichols; Calvin Y Choi; Matheen A Khuddus; Darren T Beck; Darren P Casey
Journal:  Circulation       Date:  2010-10-04       Impact factor: 29.690

Review 3.  Enhanced external counterpulsation for ischemic heart disease: a look behind the curtain.

Authors:  Randy W Braith; Darren P Casey; Darren T Beck
Journal:  Exerc Sport Sci Rev       Date:  2012-07       Impact factor: 6.230

4.  Hsp 70, hsCRP and oxidative stress in patients with acute coronary syndromes.

Authors:  Ramazan Amanvermez; Ethem Acar; Murat Günay; Ahmet Baydın; Türker Yardan; Yüksel Bek
Journal:  Bosn J Basic Med Sci       Date:  2012-05       Impact factor: 3.363

5.  "Upstream markers" provide for early identification of patients at high risk for myocardial necrosis and adverse outcomes.

Authors:  Peter A Kavsak; Dennis T Ko; Alice M Newman; Glenn E Palomaki; Viliam Lustig; Andrew R Macrae; Allan S Jaffe
Journal:  Clin Chim Acta       Date:  2007-10-03       Impact factor: 3.786

Review 6.  Systemic inflammation in heart failure--the whys and wherefores.

Authors:  Arne Yndestad; Jan Kristian Damås; Erik Oie; Thor Ueland; Lars Gullestad; Pål Aukrust
Journal:  Heart Fail Rev       Date:  2006-03       Impact factor: 4.214

Review 7.  Telomere shortening and Alzheimer's disease.

Authors:  Zhiyou Cai; Liang-Jun Yan; Anna Ratka
Journal:  Neuromolecular Med       Date:  2012-11-16       Impact factor: 3.843

8.  CCR2 promotes hepatic fibrosis in mice.

Authors:  Ekihiro Seki; Samuele de Minicis; Sayaka Inokuchi; Kojiro Taura; Katsumi Miyai; Nico van Rooijen; Robert F Schwabe; David A Brenner
Journal:  Hepatology       Date:  2009-07       Impact factor: 17.425

9.  Effect of enhanced external counterpulsation on inflammatory cytokines and adhesion molecules in patients with angina pectoris and angiographic coronary artery disease.

Authors:  Darren P Casey; C Richard Conti; Wilmer W Nichols; Calvin Y Choi; Matheen A Khuddus; Randy W Braith
Journal:  Am J Cardiol       Date:  2007-12-11       Impact factor: 2.778

Review 10.  Monocyte chemoattractant protein-1/CCL2 as a biomarker in acute coronary syndromes.

Authors:  Carlos Gonzalez-Quesada; Nikolaos G Frangogiannis
Journal:  Curr Atheroscler Rep       Date:  2009-03       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.